Pfeiffer, Steffen <br/><br/>
Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.  [electronic resource] 

 -  Transplantation  Apr 2003 
 - 953-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0041-1337 
<br/><br/><label>Standard No.: </label>10.1097/01.TP.0000058517.07194.90  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Animals<br/>Aurintricarboxylic Acid--pharmacology<br/>Blood Physiological Phenomena<br/>Blood Platelets--drug effects<br/>Complement Activation--drug effects<br/>Dipeptides--pharmacology<br/>Drug Synergism<br/>Graft Rejection--metabolism<br/>Graft Survival<br/>Hematocrit<br/>Histamine--blood<br/>Humans<br/>Lung--drug effects<br/>Lung Transplantation<br/>Platelet Glycoprotein GPIIb-IIIa Complex--metabolism<br/>Platelet Glycoprotein GPIb-IX Complex--metabolism<br/>Platelet Membrane Glycoproteins<br/>Swine<br/>Thrombin--biosynthesis<br/>Thromboxane B2--metabolism<br/>Transplantation, Heterologous